5) Stock-based Compensation: Schedule of stock inventive plan changes (Tables)

9 Months Ended

Sep. 30, 2019

As of June 30, 2019

Schedule of stock inventive plan changes

	Number of Class A Shares	Weighted Average Exercise Price	Number of Class C Shares	Weighted Average Exercise Price
Outstanding at December 31, 2018	1,011,274	$      4.49	577,280	$      5.15
Granted	2,000		-
Exercised	(19,796)		(63,814)
Cancelled	-		-
Outstanding at September 30, 2019	993,478	$      4.50	513,466	$      5.33
As of September 30, 2019:
Options exercisable	955,195	$      4.46	489,840	$      5.34
As of September 30, 2019:
Available options for future grant	299,351		146,425
Weighted average contractual term of options
outstanding at September 30, 2019	5.40 years		3.63 years
Weighted average contractual term of options
exercisable at September 30, 2019	5.34 years		3.37 years
Aggregated intrinsic value of options
outstanding at September 30, 2019 (1)	$765,360		$106,646
Aggregated intrinsic value of options
exercisable at September 30, 2019 (1)	$765,360		$106,646
(1) The Company used a stock price of $4.90 as of September 30, 2019 to derive intrinsic value.

AsOfJune302018

Schedule of stock inventive plan changes

	Number of Class A Shares	Weighted Average Exercise Price	Number of Class C Shares	Weighted Average Exercise Price
Outstanding at December 31, 2017	880,426	$      4.35	523,603	$      5.24
Granted	-		-
Exercised	(36,133)		-
Cancelled	(5,704)		-
Outstanding at September 30, 2018	838,589	$      4.48	523,603	$      5.24
As of September 30, 2018:
Options exercisable	805,902	$      4.46	505,227	$      5.26
As of September 30, 2018:
Available options for future grant	421,241		165,638
Weighted average contractual term of options
outstanding at September 30, 2018	6.05 years		2.69 years
Weighted average contractual term of options
exercisable at September 30, 2018	6.05 years		2.45 years
Aggregated intrinsic value of options
outstanding at September 30, 2018 (1)	$867,356		$267,943
Aggregated intrinsic value of options
exercisable at September 30, 2018 (1)	$862,157		$260,592
(1) The Company used a stock price of $5.20 as of September 30, 2018 to derive intrinsic value.